ScienceSoft Global
AI for Treatment Personalization
Use Cases, Architecture, Costs
Since 1989 in AI development and since 2005 in healthcare IT, ScienceSoft designs secure AI-powered solutions to help healthcare providers deliver more personalized and effective care.
Contributors
Senior Healthcare IT & AI Consultant, ScienceSoft
Head of AI, Principal Architect, ScienceSoft
AI-Driven Treatment Personalization in Brief
AI-driven treatment personalization helps healthcare providers tailor treatment decisions and follow-up plans to each patient’s condition, risk factors, and likely response to therapy. This process involves consolidating large volumes of relevant clinical and patient data, such as medical history, demographic data, diagnostic results, and real-time readings from monitoring devices. AI analyzes this data to support treatment planning, medication review, response monitoring, and care plan adjustment in clinician workflows.
AI Adoption in Healthcare
Healthcare organizations are moving from general AI experimentation to practical use in clinical workflows. According to a 2026 survey conducted at a large urban academic tertiary care hospital, 66.7% of hospitalists were already using AI in clinical practice for tasks related to diagnosis and treatment decisions. McKinsey’s 2025 survey shows a similar shift at the organizational level, with many healthcare providers and payers moving from pilots to scaled AI deployments.
The key factors driving AI use in treatment personalization include:
- The rising pressure on healthcare systems due to aging populations and chronic conditions.
- The increasing volume and complexity of patient data across multiple sources.
- The demand for more accurate, efficient, and personalized treatment decisions.
AI Use Cases for Treatment Personalization
AI-assisted treatment planning
Predictive ML models can support initial therapy selection and care pathway planning by analyzing medical history, lab results, imaging data, and prior treatments. Such tools can show clinicians relevant treatment alternatives, expected response, and possible risks such as complications or adverse events. A GenAI assistant can explain the key factors behind each option in natural language, with links to source evidence. This way, care teams can compare options without manually reviewing large amounts of fragmented patient data.
Medication selection and dosage optimization
Predictive models and rules-based logic can analyze allergies, chronic conditions, current medications, renal and hepatic function, prior medication response, and pharmacogenomic findings to flag safer medication options and dose adjustments for clinician review. Such solutions can flag possible adverse reactions, harmful drug interactions, and signs of ineffective treatment. When connected to smart medical devices (e.g., glucose monitors), AI can also suggest real-time dosage and medication adjustments for physician review.
Time-series and anomaly-detection models can analyze data from wearables, home monitoring devices, and patient-reported symptoms to detect whether a treatment plan is working or needs adjustment. Physicians can define patient-specific thresholds for vital signs, symptoms, and other health indicators. A GenAI assistant can summarize trends in the data and highlight notable changes for clinician review.
AI-assisted genomic interpretation and therapy matching
For precision oncology, rules-based algorithms can analyze molecular findings, biomarkers, cancer type, and prior treatments to identify therapies or trials that match eligibility criteria. Such applications compare genomic results with curated knowledge bases or clinical trial requirements to surface relevant options for clinician review. A grounded GenAI layer then presents the findings and supporting evidence to clinicians without acting as the primary matching engine.
Get AI-Driven Insights for Effective Treatment Planning
ScienceSoft’s healthcare IT consultants and AI engineers are ready to discuss your treatment personalization goals, assess relevant data sources and workflow constraints, and talk through the trade-offs of different AI implementation options for your case.
How AI-Driven Treatment Personalization Works
Drawing on their experience in designing medical AI software, ScienceSoft's software engineers provide a sample architecture for an AI-driven solution for care personalization.
Key Questions Providers Ask Before Implementing AI for Personalized Care
Do we build or buy?
Most providers start by adopting an off-the-shelf CDS tool, a pretrained AI model, or a healthcare AI platform and tailoring it to their clinical workflows. Building the core decision engine in-house is usually justified only when a large provider (e.g., an AMC) has highly specific treatment protocols, uncommon data combinations, or strict requirements that ready tools cannot meet.
But typically, most of the software engineering work goes into model implementation: mapping the AI tool to local care pathways, configuring user and approval rules, and connecting the solution to source systems like EHR.
What data should we connect to the tool first?
Start with the minimum dataset needed for one decision type. For treatment planning or medication review, that usually means diagnoses, encounters, medications, allergies, labs and vitals, and relevant clinical reports. SMART on FHIR apps can launch in the EHR context and access patient- and user-specific data through FHIR APIs.
It rarely makes sense to connect every available source on day one. Imaging, device streams, or genomic data should be added only when they directly influence the targeted decision and the care team is ready to use that information consistently.
Where will clinicians view AI output?
The AI CDS layer should support decisions inside existing workflows, not force physicians to work in a separate window. In practice, this means showing risk flags, patient summaries, treatment options, or medication warnings during chart review, care plan updates, and order entry. A separate interface may still be useful for deeper case exploration, but the core outputs should appear where clinical decisions are already being made. The less context-switching required, the higher the chance of adoption.
What makes an AI tool trustworthy enough for clinical use?
The rule of thumb: your AI tool should not produce black-box recommendations. Each recommendation should show the patient factors behind it, the guideline or protocol applied, and the exact action being suggested. All high-risk or low-confidence AI outputs should be routed to a defined reviewer, such as the attending physician, a pharmacist, or a tumor board. And any accepted, rejected, and overridden recommendations should be logged so the organization can see where the tool helps, where it creates noise, and which rules need adjustment. The content behind the recommendations also needs regular maintenance: formularies, clinical guidelines, drug interaction databases, and local care protocols must be updated on a defined schedule so the tool does not keep generating outdated advice.
When a clinician changes or rejects an AI recommendation, the most valuable part is often the reason why. Capturing override reasons helps reveal where the tool is missing context, where local care protocols differ from the vendor’s validation logic, and where recommendations may be unreliable for certain patient groups. This feedback can guide vendor discussions, local configuration changes, and ongoing model performance review after deployment.
Our Clients Say
ScienceSoft delivered a fully customized AI medical chatbot PoC in just two weeks. The attention to detail in the chatbot design, and especially the pitch deck, was amazing — with this kit on hand, we are ready to go into investor discussions confidently. I’m genuinely grateful to ScienceSoft for their hard work and would absolutely recommend them to anyone looking for top-notch results in health tech.
bioAffinity Technologies hired ScienceSoft to develop automated data analysis software for detection of lung cancer using flow cytometry. In addition to the solid technical expertise shown by ScienceSoft, its developers demonstrated a profound understanding of laboratory software specifics and integrations. I am particularly impressed by the cooperative nature of ScienceSoft’s team. They are reliable, thorough, smart, available, extremely good communicators and very friendly.
King Saud University approached ScienceSoft to explore the possibility of developing a mobile solution for the early identification of a specific medical condition. The resulting Proof of Concept exceeded expectations, and we sincerely appreciated the way it was delivered. We found ScienceSoft to be dependable and forward-thinking, and we would confidently recommend them for high-responsibility projects.
Technology Behind AI-Powered Personalized Care
Generative AI
Models
Model adaptation and efficiency
AI platforms and services
Agents and Orchestration
Traditional ML
Platforms and services
Frameworks and libraries
Programming languages
Big data
Data visualization
How to Address the Challenges of AI-Driven Treatment Personalization
AI-driven treatment personalization can help providers make more informed treatment decisions and adjust care plans faster. However, applying AI in clinical workflows comes with challenges related to adoption, data privacy, and validation.
1
Resistance to adoption
Clinicians’ concerns about AI’s reliability and potential impact on their professional autonomy can hinder its adoption. To address these anxieties, ScienceSoft recommends allocating substantial time to educating staff about AI software usage. Clinicians are more likely to embrace AI if they understand how it works and how it can benefit them. Comprehensive training programs and user guides can facilitate the integration of AI into existing routines and help clinicians confidently validate, adjust, or override AI suggestions.
2
PHI security risks in third-party AI use
A major concern comes from using third-party AI components, such as ready-made cloud AI tools, for processing patient data. Solution architects must ensure that these tools comply with applicable healthcare regulations and that PHI is not retained, reused, or logged in ways the provider cannot control. To learn more about hosting PHI and applications that process it, check our dedicated page about HIPAA-compliant cloud platforms.
ScienceSoft’s data scientists recommend using anonymized or de-identified data where possible. For workflows that require identifiable patient context, PHI exposure should be minimized by limiting what is passed to AI prompts, retrieval indexes, logs, and monitoring tools.
3
AI recommendations may rely on data that would not be available at the decision point
A treatment personalization tool may show strong validation results but perform worse in real clinical use if it was tested with information that clinicians would not have had when making the original treatment decision. This can happen when validation data includes later notes, downstream test results, order changes, or outcomes created after the decision point.
ScienceSoft recommends that providers ask vendors how they prevent this issue during model validation. Providers should check whether the tool is tested on time-based patient scenarios, whether recommendations are generated only from data available at the clinical decision point, and whether GenAI summaries and explanations follow the same rules. During pilot runs, providers should also compare AI outputs with what clinicians could reasonably know at that moment, not with information that became available later.
The Costs of Implementing AI for Patient Treatment Personalization
The costs of implementing AI for treatment personalization usually range from $80,000 to $2,000,000+, depending on whether a provider deploys an existing AI-enabled tool, customizes a vendor solution, or builds a custom clinical decision support system. The primary cost drivers include:
- The scope and complexity of AI functionality.
- The number of data sources and the volume of data to be stored and processed.
- The extent of data cleaning and preprocessing needed.
- The number and complexity of integrations with healthcare IT systems (e.g., EHR, diagnostic software, e-prescribing platforms, etc.).
- The number of integrations with medical devices.
- Security, performance, and UI/UX requirements.
- Output speed (delivering AI insights in batches or in near real time).
- Compliance-associated costs (e.g., for FDA submission of SaMD functionality).
$80,000–$200,000
For deploying and configuring an existing AI-enabled clinical tool, such as a drug interaction checker, dosage support module, or medical image analysis component, with limited integration and customization.
$200,000–$600,000
For implementing one EHR-integrated AI decision support module for a defined workflow, such as treatment planning, medication review, or follow-up prioritization. The work may include data mapping, workflow configuration, a clinician-facing interface, and pilot validation.
$500,000–$1,200,000+
For implementing a multi-source treatment personalization solution that supports several connected workflows, such as treatment planning, medication review, and response monitoring. This scope may involve EHR data, lab results, imaging data, device data, etc.
$1,000,000–$2,000,000+
For an enterprise-scale or advanced specialty implementation covering several departments, complex data types, and stricter validation requirements. This scope may involve imaging or molecular data analysis, multiple EHR or diagnostic integrations, and several AI models or rules-based services.
Insights From ScienceSoft's Healthcare IT Experts
Hadeel Abu Baker
Senior Healthcare IT & AI Consultant, ScienceSoft
Trend watch
Q1 2026 Healthcare AI Trends by ScienceSoft | March 2026
Gala Batsishcha, MD
Healthcare IT Consultant, ScienceSoft
Research
50% of Seniors May Use Wearables As Life-Saving Devices in 2030
Gala Batsishcha, MD
Healthcare IT Consultant, ScienceSoft
The Power of Personalization in Healthcare With Examples
